首页|Hsa_circ_MIB1在神经胶质瘤中的表达及临床意义

Hsa_circ_MIB1在神经胶质瘤中的表达及临床意义

Expression and clinical significance of Hsa_circ_MIB1 in glioma

扫码查看
目的 探究hsa_circ_MIB1在胶质瘤中的表达及其临床意义.方法 采用高通量测序技术检测5例胶质母细胞瘤组织及4例正常脑组织中差异表达的circRNA,挑选并鉴定出下调明显的hsa_circ_MIB1为研究对象.运用实时荧光定量PCR技术检测并比较胶质瘤组织和正常脑组织及神经胶质细胞系HEB和3种神经胶质母细胞瘤细胞系(U251、U87、SF126)中hsa_circ_MIB1的表达水平.分析hsa_circ_MIB1的表达水平与临床病理特征的关系;Kaplan-meier法分析hsa_circ_MIB1表达水平与生存期的关系;构建受试者工作特征(receiver operating characteris-tic,ROC)曲线评估hsa_circ_MIB1对神经胶质瘤诊断的灵敏度和特异性.结果 胶质瘤组织中hsa_circ_MIB1的表达量(0.28士0.63)明显低于正常脑组织(1.60士 1.56),差异有统计学意义(P<0.0001).恶性胶质瘤细胞系中的hsa_circ_MIB1表达水平均明显低于神经胶质细胞系中的表达水平(P<0.05).hsa_circ_MIB1的表达与胶质瘤患者的临床分期显著相关(x2=7.930,P<0.005),临床分期越高,hsa_circ_MIB1的表达水平越低.Kaplan-Meier生存质量分析显示hsa_circ_MIB1低表达的胶质瘤患者生存期明显长于高表达hsa_circ_MIB1的胶质瘤患者;ROC曲线诊断的临界值为0.8289,曲线下面积为0.928,其对应的灵敏度和特异度分别为100.0%和82.89%.结论 hsa_circ_MIB1在神经胶质瘤中表达量下降,其低表达与临床分期和预后相关,可作为神经胶质瘤诊断和治疗的新型分子标志物.
Objective To investigate the expression of hsa_circ_MIB1 in glioma and its clinical significance.Methods High-throughput sequencing was used to detect the differentially expressed circRNAs in five glioblastoma tissues and four normal brain tissues,and hsa_circ_MIB1,which was significantly down-regulated,was selected and identified as the study target.The expression levels of hsa_circ_MIB1 in glioma tissues and normal brain tissues and glial cell line HEB and three glioblastoma cell lines(U251,U87,SF126)were detected and compared using real-time fluorescence quantita-tive PCR.The relationship between hsa_circ_MIB1 expression levels and clinicopathological characteristics was ana-lyzed;the Kaplan-meier method was used to analyze the relationship between hsa_circ_MIB1 expression levels and sur-vival;subject operating characteristic(ROC)curves were constructed to assess the effect of hsa_circ_MIB1 on glioma.The sensitivity and specificity of hsa_circ_MIB1 for glioma diagnosis were assessed by constructing receiver operating characteristic(ROC)curves.Results The expression of hsa_circ_MIB1 in glioma tissues(0.28±0.63)was significant-ly lower than that in normal brain tissues(1.60±1.56),and the difference was statistically significant(P<0.0001).The expression levels of hsa_circ_MIB1 in all malignant glioma cell lines were significantly lower than those in glial cell lines(P<0.05).hsa_circ_MIB1 expression was significantly correlated with the clinical stage of glioma patients(x2=7.930,P<0.005),and the higher the clinical stage,the lower the expression level of hsa_circ_MIB1 Kaplan-Meier sur-vival quality analysis showed that glioma patients with low hsa circ MIB1 expression had significantly longer survival than those with high hsa_circ_MIB1 expression;the critical value of the ROC curve for diagnosis was 0.8289 and the area under the curve was 0.928,which corresponded to a sensitivity and specificity of 100.0%and 82.89%,respective-ly.Conclusion hsa_circ_MIB1 expression is decreased in glioma,and its low expression correlates with clinical staging and prognosis,and can be used as a novel molecular marker for glioma diagnosis and treatment.

circular RNAgliomahsa_circ_MIB1

罗伶俐、陈思敏

展开 >

湖南省儿童医院检验中心,湖南长沙 410007

湖南省益阳市中心医院检验科,湖南益阳 413099

环状RNA 胶质瘤 hsa_circ_MIB1

2024

中国实验诊断学
吉林大学中日联谊医院 上海交通大学医学院附属瑞金医院

中国实验诊断学

CSTPCD
影响因子:1.273
ISSN:1007-4287
年,卷(期):2024.28(3)
  • 16